Director/PDMR Shareholding

Quantum Helium

21/04/2026 08:54

RNS Number : 3054B

Quantum Helium Limited

21 April 2026

 

 

21 April 2026

 

Quantum Helium Limited

("Quantum" or the "Company")

 

 

Director / PDMR Shareholding

Quantum Helium Limited (AIM: QHE) announces that Executive Chairman Carl Dumbrell has informed the Company that on 17 April 2026 he purchased 27,500,000 Ordinary Shares in the Company and on 20 April 2026 he purchased a further 33,268,948 Ordinary Shares in the Company, both at a price of 0.031 pence per share.

The Company has also been informed that Executive Director, Andrew Scott, purchased 52,000,000 Ordinary Shares in the Company on 20 April 2026 at a price of 0.033 pence per share.

Non-Executive Director, Nigel Harvey, has also informed the Company that on 20 April he purchased 33,125,000 Ordinary shares in the Company at a price of 0.032 pence per share.

Following these trades, Carl Dumbrell has a beneficial interest in 181,216,120 Ordinary Shares, representing 0.36% of the current total voting rights of the Company, Andrew Scott has a beneficial interest in 226,791,702 Ordinary Shares, representing 0.45% of the current total voting rights of the Company and Nigel Harvey has a beneficial interest in 157,746,952 Ordinary Shares, representing 0.32% of the current total voting rights of the Company.

Note: The figure used to determine the Company's current total voting rights reflects the enlarged share capital following the announcement on 17 April 2026 of a £5 million institutional placing and the issue of 16,666,666,667 new ordinary shares, resulting in total voting rights of 49,985,396,722.

 

 

Enquiries:

Quantum Helium Limited
Carl Dumbrell
Chairman
NOMAD and Joint Broker
SP Angel Corporate Finance LLP
Stuart Gledhill / Richard Hail / Adam Cowl
+44 (0) 20 3470 0470
Brand Communications
Alan Green
Tel: +44 (0) 7976 431608
Joint Broker
CMC Markets UK Plc
Douglas Crippen
+44 (0) 020 3003 8632

 

Updates on the Company's activities are regularly posted on its website: www.quantum-helium.com

 

Notes to editors

Quantum (AIM: QHE) is a helium, hydrogen and hydrocarbon exploration, development, and production company with projects in the US and Australia. Quantum's strategic objectives remain consistent: to identify opportunities which will provide operating cash flow and have development upside, in conjunction with progressing exploration. The Company has several projects in the US, in addition to royalty interests in Australia.

 

 

 

1.
Details of PDMR/person closely associated with them ("PCA")
a)
Name
1) Carl Dumbrell
2) Andrew Scott
3) Nigel Harvey
2.
Reason for the notification
a)
Position/status
1) Executive Chairman
2) Executive Director
3) Non-Executive Director
b)
Initial notification/
 amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Full name of the entity
Quantum Helium Limited
b)
Legal Entity Identifier code
213800PWZID9URNNGZ54
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument

 Identification code
Ordinary shares of Quantum Helium Ltd



 AU0000XINET1
b)
Nature of the transaction
Purchase of Ordinary Shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
1) 0.031p
2) 0.033p
3) 0.032p
60,768,948
52,000,000
33,125,000
d)
Aggregated information
- Aggregated volume
- Price
Single transaction as in 4c) above
e)
Date of the transaction
1) 17 and 20 April 2026
2) 20 April 2026
3) 20 April 2026
f)
Place of the transaction
1)London Stock Exchange
2)London Stock Exchange
3) Off Market

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHFIFEDSFILFIR